Powered by TradingView

Zynerba Pharmaceuticals, Inc.

Exchange: NASDAQ

Zynerba Pharmaceuticals develops synthetic cannabinoid based medicines to help treat a wide-range of needs. Currently, the company has a synthetic gel in phase 2 of clinical development for epilepsy.

Search for ZYNE news >>

Do you represent Zynerba Pharmaceuticals, Inc.? Get in touch to claim your listing.

Contact Info:

More Cannabis Stocks

Learn about other publicly-traded cannabis & hemp companies:

New to Cannabis? Start Here.

The Ganjapreneur beginner's guide to all things cannabis.